Pfizer will lower its stake in Haleon from 15 percent to about 7.3% by selling shares worth 2.50 billion pounds ($3.05 ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

Jemperli is central to GSK’s immuno-oncology research and development efforts. Credit: GSK. GSK has reported that the double-blind, randomised Phase III FIRST-ENGOT-OV44 trial of Zejula (niraparib) ...

药界的世界巨头。葛兰素史克股份有限公司（GlaxoSmithKline plc，GSK）是总部位于英国伦敦的全球第三大的制药、生物以及卫生保健公司（营业额排在强生公司、辉瑞之后）。GSK是一家覆盖抗感染、中枢神经系统、呼吸科、肠胃／代谢、肿瘤和疫苗领域的以研发为 ...